Tirzepatide 99.8% Purity — Xingruida XdrCertificate of Analysis · Independent third-party lab result
LabG tested this tirzepatide batch (2025.01.15) at 99.8% purity via HPLC and mass quantification. The tested quantity of 45.8mg showed a significant 14.5% deviation from the 40mg label. Endotoxin status is not applicable, and the test is recent (3-6 months old). Customers can cross-check on the lab's public verification URL.
- high quantity deviation
- no endotoxin test
- Test date
- 2025-12-29
- Testing lab
- LabG
- Batch / lot
- 2025.01.15
- Quantity
- 45.8mg
- Endotoxins
- —
- Assay method
- HPLC + mass quantification + endotoxins
- Test score
- 7.4
- Label dose
- 40mg
How this result compares
This Tirzepatide certificate's tested purity of 99.80% ranks higher than 43% of the 7378 Tirzepatide certificates with a purity result we have catalogued (median 99.82%).
Tested 2025-12-29 by LabG via HPLC + mass quantification + endotoxins. This test is newer than 50% of our catalogued Tirzepatide certificates.
Xingruida Xdr has 73 certificates in our corpus, including 21 for Tirzepatide at a median tested purity of 99.80%.
Test report image
Finnrick
Artifact capturedWe have the certificate image (SHA-256 hash captured) — you can verify it loads from the upstream lab and matches the artifact shown here.
Verify on the upstream labSaved source document
sha256:3eba5b022759d902…
— immutable copy held by TitrateLab